Suppr超能文献

肝硬化患者脾切除术后肝细胞癌的危险因素。

Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic Patients.

机构信息

Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan.

出版信息

Am Surg. 2023 Apr;89(4):769-777. doi: 10.1177/00031348211041562. Epub 2021 Aug 30.

Abstract

BACKGROUND

Splenectomy is sometimes indicated for portal hypertension caused by cirrhosis, which is a risk for hepatic carcinogenesis. This study aimed to identify risk factors for hepatocellular carcinoma (HCC) development after splenectomy.

METHODS

This retrospective study included 65 patients who underwent splenectomy for portal hypertension between 2009 and 2017. Cox regression analyses were performed to identify factors related to HCC development after splenectomy. The predictive index for HCC development was constructed from the results of multivariate analysis, and 3 risk-dependent groups were defined. Discrimination among the groups was estimated using Kaplan-Meier curves and the log-rank test.

RESULTS

Post-splenectomy, 36.9% of patients developed HCC. In the univariate analysis, the etiology of cirrhosis (hepatitis C virus antibody, = .005, and hepatitis B surface antigen, = .008, referring to non-B and non-C patients, respectively), presence of HCC history ( < .001), and preoperative hemoglobin level ( = .007) were related to HCC development, and the presence of HCC history ( = .002) and preoperative hemoglobin level ( = .022) were independent risk factors. The predictive index classified three groups at risk; the hazards in each group were significantly different (low vs middle risk, = .035, and middle vs high risk, = .011).

DISCUSSION

The etiology of cirrhosis, presence of HCC history, and hemoglobin level were associated with HCC development after splenectomy. The predictive model may aid in HCC surveillance after splenectomy for patients with portal hypertension.

摘要

背景

脾切除术有时用于由肝硬化引起的门静脉高压症,这是肝癌发生的一个风险因素。本研究旨在确定脾切除术后肝细胞癌(HCC)发展的危险因素。

方法

本回顾性研究纳入了 2009 年至 2017 年间因门静脉高压症接受脾切除术的 65 例患者。采用 Cox 回归分析确定脾切除术后 HCC 发展的相关因素。从多因素分析结果构建 HCC 发展的预测指数,并定义 3 个风险相关组。通过 Kaplan-Meier 曲线和对数秩检验评估组间的差异。

结果

脾切除术后,36.9%的患者发生 HCC。单因素分析中,肝硬化病因(丙型肝炎病毒抗体, =.005,乙型肝炎表面抗原, =.008,分别指非 B 型和非 C 型患者)、HCC 病史( <.001)和术前血红蛋白水平( =.007)与 HCC 发展相关,而 HCC 病史( =.002)和术前血红蛋白水平( =.022)是独立的危险因素。预测指数将患者分为 3 个危险组;每组的风险显著不同(低危与中危组, =.035,中危与高危组, =.011)。

讨论

肝硬化病因、HCC 病史和血红蛋白水平与脾切除术后 HCC 的发展相关。该预测模型可能有助于监测门静脉高压症患者脾切除术后的 HCC。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验